Context: Breast cancer represents a significant public health problem concern
the world, given its frequency (20% to 25% of female cancers) and diagnosis
clinical stage with a particular frequency of locally advanced cancers and
inflammatory forms. Objectives: To describe the socio-demographic,
clinical and histological characteristics of breast cancer at the University
Clinics of Kinshasa. Methods: A descriptive and retrospective study was
completed at University Clinics of Kinshasa from 1 January 2003 to 30 July
2018, including 300 cases of breast cancer diagnosed and treated. Results:
The mean age of women at diagnosis was 47.5 ± 10.8 years. Most of the patients
were married, multipara with an average parity of 3.7 ± 2.5 and non-menopausal.
Breast mass was the main reason for medical visit (47.5%) and the majority of
patients consulted 12 months after the onset
of the disease (36.3%) at stage 3 (56%) and node extension was observed in
61.3%. The average size of the breast mass was 8.02 ± 3.7 cm. The
infiltrating ductal carcinoma was the most common histological type in 82.5% of
cases; the majority of tumors were histo-pronostic II in 47.5% of cases. 83% of
the tumors were hormonal-dependent. Only
35.9% of the tumors over-expressed the HER 2/Neu receptor. Conclusion:
Most patients consulted more than 12 months after the onset of the disease and
the diagnosis was made at advanced stages. The tumor was large at diagnosis.
The left breast was the most affected. The majority of tumors are of high
histopronostic grade and are hormonal-dependent.
References
[1]
Stewart, B.W. and Kleihues, P. (Eds.) (2005) Le cancer dans le monde. IARC Press, Lyon.
[2]
Boyle, P. and Levin, B. (Eds.) (2008) World Cancer Report 2008. International Agency for Research on Cancer (IARC), Geneva, 1-6-2010.
[3]
Ben Gobrane, H.L., Hajjem, S., SKhiri, H.A., Achour, N. and Hsairi, M. (2011) Mortality from Cancer in Tunisia: Calculating Years of Life Lost. Santé Publique, 23, 31-40. https://doi.org/10.3917/spub.111.0031
[4]
Ben Ahmed, S., Aloulou, S., Bibi, M., Landolsi, A., Nouira, M. and Ben Fatma, L. (2002). Pronostic du cancer du sein chez les femmes tunisiennes: Analyse d’une série hospitalière de 729 patientes. Santé Publique, 14, 231-241.
https://doi.org/10.3917/spub.023.0231
[5]
International Agency for Research on Cancer (World Health Organization) (2013) Latest World Cancer Statistics, Global Cancer Burden Rises to 14.1 Million New Cases in 2012: Marked Increase in Breast Cancers Must Be Addressed.
http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf
[6]
Amsalhem, P., Etessami, R. and Morère, J.F. (2007) Epidémiologie, facteurs de risque, dépistage. In: Le cancer du sein, Springer, Paris, 11-22.
https://doi.org/10.1007/978-2-287-36073-2_1
[7]
Gueye, S.M.K., Gueye, M., Coulbary, S.A., Diouf, A. and Moreau, J.C. (2016) Problématique de la prise en charge des cancers du sein au Sénégal: Une approche transversale. The Pan African Medical Journal, 25, Article No. 3.
https://doi.org/10.11604/pamj.2016.25.3.3785
[8]
Maajani, K., Khodadost, M., Fattahi, A. and Pirouzi, A. (2020) Survival Rates of Patients with Breast Cancer in Countries in the Eastern Mediterranean Region: A Systematic Review and Meta-Analysis. Eastern Mediterranean Health Journal, 26, 219-232. https://doi.org/10.26719/2020.26.2.219
[9]
Arveux, P. and Bertaut, A. (2013) Epidemiology of Breast Cancer. Revue du Praticien, 63, 1362-1366.
[10]
Parkin, D.M., Bray, F., Ferlay, J. and Pisani, P. (2005) Global Cancer Statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74-108.
https://doi.org/10.3322/canjclin.55.2.74
[11]
Hospices Civils de Lyon/InVS/INCa/Francim/Inserm (2009) Projections de l’incidence et de la mortalité par cancer en France pour l’année 2008.
[12]
Tabar, L., Yen, M.-F., Vitak, B., Tony Chen, H.-H., Smith, R.A. and Duffy, S.W. (2003) Mammography Service Screening and Mortality in Breast Cancer Patients: 20-Year Follow-Up before and after Introduction of Screening. Lancet, 361, 1405-1410.
https://doi.org/10.1016/S0140-6736(03)13143-1
[13]
Otto, S.J., Fracheboud, J., Looman, C.W.N., Broeders, M.J.M., Boer, R., Hendriks, J.H.C.L., Verbeek, A.L.M., de Koning, H.J. and National Evaluation Team for Breast Cancer Screening (2003) Initiation of Population-Based Mammography Screening in Dutch Municipalities and Effect on Breast-Cancer Mortality: A Systematic Review. Lancet, 361, 1411-1417. https://doi.org/10.1016/S0140-6736(03)13132-7
[14]
Mbala, et al. (2010) Profil clinique, histopathologique et moléculaire du cancer mammaire chez la femme congolaise de Kinshasa 2010. Thèse d’Agrégation à l’Enseignement Supérieur et universitaire, Faculté de Médecine, Unikin.
[15]
Ben Gobrane, H., Fakhfakh, R., Rahal, K., Ben Ayed, F., Maalej, M., Ben Abdallah, M., et al. (2007) Pronostic du cancer du sein à l’institut de carcinologie salah azaiez de Tunis. Eastern Mediterranean Health Journal, 13, 309-318.
[16]
Sangwa, L.G., Nguma, M., Tozin, R., Mbiye, K., Mbala, L., Kimpiatu, K., et al. (1998) Etude épidemiologique des stades cliniques des cancers gynécologiques: Cas des Cliniques Universitaires de Kinshasa. Panorama médical, 3, 185-188.
[17]
Sando, Z., Jovanny Tsuala, J.F., Ymele, F.F., Hortence, J.F. and Telesphore, E. (2014) Profil des cancers gynécologiques et mammaires à Yaoundé—Cameroun. Pan African Medical Journal, 17, Article No. 28.
https://doi.org/10.11604/pamj.2014.17.28.3447
[18]
Chan, P.D. and Johnson, S.M. (2006) Gynecology and Obstetrics. Current Clinical Strategies Publishing, Laguna Hills, 106.
[19]
Essiben, F., Foumane, P., Mboudou, E.T., Dohbit, J.S., MveKoh, V. and Ndom, P. (2013) Diagnostic et traitement du cancer de sein au Cameroun: à propos de 65 cas. Mali Médical, 28, 1-5.
[20]
Diakite, N., Sanogo, Z.Z. and Traore Cheick, B. (2011) Sékou Koumare, cancer du sein: aspects cliniques et thérapeutiques dans le service chirurgie du CHU du point G, 2011. Thèse de doctorat, faculté de médecine, université de Bamako, Bamako.
[21]
Bouzoubaa, W., Laadioui, M., Jayi, S., Alaoui, F.Z.F., Bouguern, H., Chaara, H., Abdelilah Melhouf, M. (2015) Oncoplastie avec conservation mammaire dans le traitement du cancer du sein: à propos de 16 cas, CHU Hassan II, Fès, Maroc. Pan African Medical Journal, 20, Article No. 180.
https://doi.org/10.11604/pamj.2015.20.180.4897
[22]
Sofia, A., Mahfoudi, A., El Omrani, A. and Khouchani, M. (2015) Facteurs liés au diagnostic tardif du cancer du sein: Expérience du CHU Mohammed VI Marrakec. Pan African Medical Journal, 21, Article No. 162.
https://doi.org/10.11604/pamj.2015.21.162.4363
[23]
Dem, A., Traoré, B., Dieng, M.M., Diop, P.S., Ouajdi, T., Lalami, M.T., et al. (2008) Les cancers gynécologiques et mammaires à l’Institut du cancer de Dakar John Libbey Eurotext. Cahiers d’études et de recherches francophones, 18, 25-29.
https://doi.org/10.1684/san.2008.0093
[24]
Institut National du Cancer (INCA) (2012) étude sur les délais de prise en charge des cancers du sein et du poumon—INCa—juin 2012. ENORS, Collection études & Expertises, France, 1-106.
[25]
(2012) Du diagnostic au premier traitement: Délais de prise en charge des cancers enregistrés par les registres spécialisés du réseau Francim 1999-2008. Collection état des lieux & des connaissances, ouvrage édité par l’INCa, Boulogne-Billancourt, 3-42.
[26]
Richards, M.A., Westcombe, A.M., Love, S.B. and Ramirez, A.J. (1999) Influence of Delay on Survival in Patients with Breast Cancer: A Systematic Review. Lancet, 353, 1119-1126. https://doi.org/10.1016/S0140-6736(99)02143-1
[27]
Lopes, L.V., Frederico, A.T. and Santos, L.L. (2012) Cancer du sein en Angola: une étude préliminaire. Oarec nouvelles Juin, 22, 2.
[28]
Durbard-Gault, M., Chirpaz, E. and Mathoulin-Pelissier, S. (2013) Cancer du sein chez la femme moins de 50 ans à la réunion entre 2005-2010. Thèse de doctorat, Faculté de Médecine humaine et Pathologie, Université de Bordeaux 2, Bordeaux.
[29]
Sarré, B., Ogougbèmy, M., Dotou, C., Lopy, J., Ndionne, P., Frank, K., Drave, K. and Diouf, M.B. (2006) Epidemiological, Therapeutic and Prognostic Aspects of Breast Cancer: About 473 Cases Collected in Hospital Principal de Dakar. Dakar Medical, 51, 92-96.
[30]
Dalenc, F., Comet, B., Lacroix-Triki, M., Charitansky, H., Chauvet, M.P. and Ceugnart, L. (2010) Les cancers du sein pT1a et pT1b ont-ils tous un bon pronostic? 31es Journées de la SFSPM. La Lettre du Sénologue, No. 48, 44-50.
[31]
Abbass, F.S., Bennis, S., Znati, K., Akasbi, Y., Amrani, J.K. and El Mesbahi, O. (2011) Le profil épidémiologique et biologique du cancer du sein à Fès-Boulemane (Maroc). La Revue de Santé de la Méditerranée orientale, 17, 930-936.
https://doi.org/10.26719/2011.17.12.930
[32]
Diéras, V. and Pierga, J.Y. (2013) Avancées significatives dans le traitement médical du cancer du sein métastatique: résultats des essais de phase III. La Lettre du Cancérologue, 22, 178-182.
[33]
Blaizel, O., Ferland, A. and Morin, J. (2006) à la recherche des patientes présentant un cancer HER2/neu positif. Pharmactuel, 39, 252-260.
